tirzepatide surpass-4 for the Maintenance of Body Weight Reduction: Rationale, Design, and Baseline Characteristics of SURMOUNT‐MAINTAIN - Horn - 2025 - Obesity Efficacy and safety of tirzepatide

Lab Invest 1999;79:10891099

This might involve switching to alternative agents, modifying dosages, or implementing combination therapies specifically chosen to overcome identified resistance mechanisms [237]

Oral Hygiene It can be helpful to rinse your mouth before meals to cleanse your palate

DPP-4 inhibitors: Generally discontinued when starting GLP-1 since both affect the incretin system

Britta Reierson , MD, FAAFP, a board-certified family physician and obesity medicine specialist at knownwell, a metabolic health company , cites a national Michigan Medicine survey that shows that up to 60,000 young adults are using GLP-1s on a regular basis, compared to 8,700 a month in 2020

& Garcia-Carmona, F